Although the market for real-world evidence solutions was already growing, an increase in regulatory support and an increase in research and development spending are expected to boost the market growth. Furthermore, the shift from volume-based care to value-based care is expected to fuel market growth. In response to the COVID-19 pandemic, many market players began experiencing general business disruptions; however, IQVIA reported that it was unable to perform on-site monitoring and deliver offerings that relied on in-person gatherings or face-to-face interactions. However, in response to these challenges, IQVIA accelerated its cost containment efforts by expanding a variety of cost containment actions for reducing the impact on profitability.